Skip to content
sellWeak cluster of 5

STONE HEISZ LESLIE sold $435k of EW

director at Edwards Lifesciences Corp. 5,739 shares at an average of $75.86, traded Feb 13, 2025, filed Feb 13, 2025.

Warning score
37
Value
$435k
5,739 shares
Holdings after
30,035
-16% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001225208-25-001709, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 13, 2025MOption exercise
Common Stock
+5,739$45.32$260k35,774Feb 13, 2025
Feb 13, 2025SOpen-market sale
Common Stock
-5,739$75.86$435k30,035Feb 13, 2025
Feb 13, 2025MOption exercise
Director Stock Option (Right to Acquire)derivative
-5,739$0.00$00Feb 13, 2025

Related signals

Other insiders at Edwards Lifesciences Corp and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
27Weaksell 210b5-1EW
Edwards Lifesciences Corp
Ullem Scott B.
CVP, Chief Financial Officer
$797k11,250
20Weaksell 410b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$646k9,500
0Weaksell 410b5-1EW
Edwards Lifesciences Corp
Lippis Daniel J.
CVP, JAPAC
$28k400
22Weaksell 410b5-1EW
Edwards Lifesciences Corp
Zovighian Bernard J
CEO
$428k6,164
34Weaksell 510b5-1EW
Edwards Lifesciences Corp
Ullem Scott B.
CVP, Chief Financial Officer
$796k11,250
32Weaksell 5EW
Edwards Lifesciences Corp
LORANGER STEVEN R
director
$439k5,739
18Weaksell 510b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$492k6,500
1Weaksell 510b5-1EW
Edwards Lifesciences Corp
Lippis Daniel J.
CVP, JAPAC
$38k500
35Weaksell 510b5-1EW
Edwards Lifesciences Corp
Ullem Scott B.
CVP, Chief Financial Officer
$852k11,250
3Weaksell 210b5-1EW
Edwards Lifesciences Corp
BOBO DONALD E JR
CVP,Strategy/Corp Development
$344k5,000

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

STONE HEISZ LESLIE sold $435k of EW | InsiderTell